Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02921087 · ClinicalTrials.gov registry record · NA

Connecting Contact Lenses and Digital Technology

A NA study, sponsored by State University of New York College of Optometry.

Completed
Registry status
NA
Development phase
23
Enrollment target

NCT02921087: Completed NA study, sponsored by State University of New York College of Optometry.

NCT02921087 is a NA study that has completed, run by State University of New York College of Optometry. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02921087, a NA study, has completed, sponsored by State University of New York College of Optometry.

COMPLETED
Registry status
NA
Development phase
23 participants
Enrollment target

Study Summary

This study seeks to address whether or not different types of daily disposable soft contact lenses may be a beneficial option for patients complaining of eye strain and visual discomfort while using digital devices.

Primary Outcome

The primary outcome measure was change in average score on a ten question Visual Comfort Survey using a Visual Analogue Scale (VAS) from baseline to day 7 in multifocal contact lenses and single vision contact lenses. The Visual Analogue Scale ranges from 0-100 (100 being the worst symptoms) for each of the ten questions. The maximum total score is 1000, the minimum total score is 0 (no symptoms).

Interventions

  • DEVICE Test Daily Disposable Soft Contact Lenses
  • DEVICE Control Daily Disposable Soft Contact Lenses

Trial Details

FieldValue
Enrollment Target 23 participants
Start Date 2017-01
Est. Completion 2017-11-20
Phase NA

What the finished NCT02921087 record still lists

NCT02921087 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Test Daily Disposable Soft Contact Lenses is the first listed.

NCT02921087 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT02921087 about?

NCT02921087 is a clinical study titled "Connecting Contact Lenses and Digital Technology". This study seeks to address whether or not different types of daily disposable soft contact lenses may be a beneficial option for patients complaining of eye strain and visual discomfort while using digital devices.

What is the current status of trial NCT02921087?

This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2017-01. Estimated completion is 2017-11-20.

What interventions are being tested in trial NCT02921087?

The interventions under investigation include: Test Daily Disposable Soft Contact Lenses (DEVICE), Control Daily Disposable Soft Contact Lenses (DEVICE).

Who is sponsoring clinical trial NCT02921087?

This trial is sponsored by State University of New York College of Optometry, which has 14 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT02921087's enrollment target sits among peer trials

23 1755th of 2000 higher than 245 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03616041 · 23 participants

    Capsule Endoscopy for Severe Hematochezia

  • NCT04348747 · 23 participants · Phase 2

    Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer

  • NCT04587687 · 23 participants · Phase 2

    Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma

  • NCT04715022 · 23 participants · Phase 1

    Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02921087, the US trial registry maintained by the National Library of Medicine. NCT02921087 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.